This study aimed to determine the expression of Nm23-H1 in colorectal cancer and liver metastases and to correlate Nm23-H1 expression with clinicopathological variables. Specimens from 59 primary colorectal cancers and five liver metastases were studied using Northern blot hybridisation. The mean ± s.e. of tumour/normal (T/N) ratio of Nm23-H1 RNA expression was 4.3 ± 0.4 (P < 0.001) and 5.1 ± 0.90 (P < 0.01) for colorectal cancer and liver metastases respectively. No significant relationship was observed between the level of Nm23-H1 RNA and the patient's age, sex, tumour location, differentiation, presence of lymph node involvement or distant metastases. Nm23-H1 RNA level was 2.6 ± 0.5 for tumour size less than 3.0 cm and 4.6 ± 0.5 for those ≥ 3.0 cm (P = 0.05). There appeared to be a trend between increasing relative Nm23-H1 RNA and bowel wall invasion, irrespective of metastatic status (T1 = 1.9 ± 0.3, T2 = 4.1 ± 0.6, T3 = 4.1 ± 0.5 and T4 = 6.4 ± 1.6). This difference was statistically significant when T1 was compared against ≥ T2 lesions (P = 0.01). Western blot analysis reveals two Nm23H-1 bands (17.0 kDa and 18.5 kDa). In 16 colorectal patients, the T/N fold-increase in protein expression was 2.66 ± 0.46 (P < 0.001) and 2.40 ± 0.32 (P < 0.001) for the 17.0 and 18.5 kDa band respectively. Both Nm23-H1 RNA and protein levels in primary colorectal cancers do not appear to correlate with synchronous regional or distant metastases. Since Nm23-H1 RNA expression is associated with increasing tumour size and tumour local invasion, Nm23-H1 RNA expression may be associated with local disease progression.
ASJC Scopus subject areas
- Cancer Research